CONSORT MED ADR Cash Flow - Quarterly (OTCMKTS:CSRMY)

Add to My Stocks
$14.39 $0 (0%) CSRMY stock closing price Sep 21, 2018 (Closing)

For analyzing any company like CONSORT MED ADR from an investment perspective, its important to check the cash flow statement. While its important to look at the CONSORT MED ADR debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as CONSORT MED ADR revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. CONSORT MED ADR cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. CONSORT MED ADR had cash and cash equivalents of $20.95M at the beginning of the quarter and $28.64M at quarter end for 2018 Q4. The cash from operating activities for CONSORT MED ADR is $ 2018 Q4, which saw an increase from previous quarter.

View and download details of CONSORT MED ADR cash flows for latest & last 40 quarters
show more
Fiscal year is May - Apr2018 Q42018 Q22017 Q4
Net Income Cash Flow
29.17M9.86M28.32M
Depreciation Depletion Amortization Cash-Flow34.26M16.84M32.98M
Net Increase (Decrease) in Assets Liabilities-20.74M-11.31M-5.82M
Cash From (used in) Discontinued Operations---
Other Adjustments Net-4.86M-2.84M
Net Cash from (used by) Operating Activities
43.36M20.26M52.64M
Increase (Decrease) in Prop Plant And Equipment-27.97M-13.42M-23.28M
Acquisition Disposition of Subsidiaires---
Increase (Decrease) in Investments---4.01M
Other Cash Inflow (Outflow) from Investment Activities-1.47M-0.13M-
Net Cash from (used by) Investment Activities
-29.44M-13.55M-27.29M
Issuance (Purchase) of Equity Shares-2.27M-2.23M-3.1M
Issuance (Repayment) of Debt Securities3.88M15.13M-5.3M
Increase (Decrease) in Bank & Other Borrowings---
Payment of Dividends & Other Cash Distributions-13.51M-8.55M-12.41M
Other Cash from (used by) Financing Activities---
Net Cash from (used by) Financing Activities
-11.91M4.34M-20.82M
Effect of Exchange Rate Changes on Cash---0.38M
Net Change in Cash & Cash Equivalents
2.67M11.18M4.13M
Cash & Equivalents at Beginning of Year20.95M--
Cash & Equivalents at Year End28.64M36.7M25.09M
All figures in USD. M: Millions of USD, B: Billions of USD.

Click here to view our BioCryst Pharma financial analysis

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The CONSORT MED ADR stock price history and CONSORT MED ADR stock comparison chart inevitably reflect its cash flow situation.

  • CONSORT MED ADR saw a negative change in Net Change in Cash and Cash Equivalents of $2.67M till 2018 Q4. Apart from the CONSORT MED ADR stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a positive value of $43.36M for CSRMY.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-29.44M for CSRMY stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash flow from financing activities shows the flow of cash between CONSORT MED ADR and its owners and creditors and was $-11.91M till 2018 Q4. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For CONSORT MED ADR Cash Flow

Quarterly Cash Flow Statements For CONSORT MED ADR Peers

BioCryst Pharma cash flow, DOVA PHARMACUET cash flow, Sagent Pharma cash flow